Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Neonates, Children and Adolescents: A Critical Analysis of Current Data

Laura Ferreras-Antolin*, Andrew Borman, Antonia Diederichs, Adilia Warris, Thomas Lehrnbecher

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

6 Citations (Scopus)

Abstract

β-D-glucan (BDG) is a cell wall component of many pathogenic fungi. The detection of BDG as an assay is clinically broadly used as a diagnostic tool. However, the current data on BDG in paediatrics are limited, prompting specific considerations about when BDG can be used in neonates and children. We aimed to analyse the available data for the use of serum BDG in neonates and immunocompromised children and adolescents; as well as to understand the extent and characteristics of the use of BDG in children in Europe.

Original languageEnglish
Article number1262
JournalJournal of Fungi
Volume8
Issue number12
DOIs
Publication statusPublished - Dec 2022

Bibliographical note

Publisher Copyright:
© 2022 by the authors.

Keywords

  • fungal diagnostics
  • invasive fungal infections in children
  • neonatal invasive candidiasis
  • β-D-glucan

Fingerprint

Dive into the research topics of 'Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Neonates, Children and Adolescents: A Critical Analysis of Current Data'. Together they form a unique fingerprint.

Cite this